Rosuvastatin Drug Profile

What is Rosuvastatin?

Rosuvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated blood lipids. Rosuvastatin is considered one of the most potent statins available and is often prescribed when other cholesterol-lowering medications have proven insufficient.

Uses

Rosuvastatin is approved for several cardiovascular and lipid-related conditions:

• High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels in patients with elevated lipid levels
• Mixed dyslipidemia: Treats patients with multiple lipid abnormalities, including high triglycerides and low HDL (“good”) cholesterol
• Primary prevention of cardiovascular disease: Reduces heart attack and stroke risk in patients with normal cholesterol but other cardiovascular risk factors
• Familial hypercholesterolemia: Manages inherited conditions causing extremely high cholesterol levels
• Secondary cardiovascular prevention: Prevents future cardiac events in patients with existing heart disease or diabetes

How it works

Rosuvastatin works by blocking HMG-CoA reductase, an enzyme essential for cholesterol production in the liver. When this enzyme is inhibited, the liver produces less cholesterol and increases the uptake of LDL cholesterol from the bloodstream. This dual action significantly reduces blood cholesterol levels and helps prevent the formation of arterial plaques that can lead to heart attacks and strokes.

Side effects

Common side effects include:

Submit Your Paper

• Headache
• Muscle aches and weakness
• Abdominal pain
• Nausea
• Dizziness
• Constipation
• Joint pain
• Sleep disturbances

Serious side effects requiring immediate medical attention:

• Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
• Dark-colored urine or decreased urination
• Liver problems (yellowing of skin or eyes, severe fatigue)
• Unexplained muscle cramps with fever
• Memory problems or confusion

Warnings and precautions

• Muscle toxicity: Patients should report any unexplained muscle pain, as statins can rarely cause serious muscle breakdown (rhabdomyolysis)
• Liver function: Regular liver enzyme monitoring is recommended, especially during the first year of treatment
• Pregnancy and breastfeeding: Rosuvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus
• Kidney disease: Dosage adjustments may be necessary in patients with severe kidney impairment
• Asian populations: Lower starting doses are often recommended due to increased drug sensitivity in some Asian patients

Interactions

Rosuvastatin can interact with several medications and supplements:

• Cyclosporine: Significantly increases rosuvastatin levels, requiring dose reduction
• Gemfibrozil: Increases muscle toxicity risk when combined with rosuvastatin
• Warfarin: May enhance anticoagulant effects, requiring closer INR monitoring
• Antacids: Can reduce rosuvastatin absorption when taken simultaneously
• Fenofibrate: Combination increases risk of muscle-related side effects
• Protease inhibitors: HIV medications can significantly increase statin blood levels
• Red yeast rice: Contains natural statins and may increase side effect risk
• Niacin (high doses): May increase muscle toxicity when combined with statins

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing ranges from 5 mg to 40 mg taken once daily, usually in the evening. Most patients start with 10-20 mg daily, with dosage adjustments made every 2-4 weeks based on cholesterol response and tolerability. The maximum recommended dose is 40 mg daily, which is reserved for patients with severe cholesterol elevations who have not achieved target levels on lower doses. Patients with kidney problems or those of Asian descent may require lower starting doses. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, risk factors, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).